While I disagree that we won’t get FDA approval. I do agree that we are well positioned now that “if” that’s a massive “if” we didn’t get FDA we have de-risked exponentially from receiving European and Australian approvals, with sleep apnea applications in the pipeline, not to mention Lockheed Martin partnership progression or any other left field announcements. So from a risk basis there are many reason not to be concerned about it. Rest assured that if you hold RAP currently you can sleep at night knowing the company is going places! We are just waiting for the cherry to be put on top now!
- Forums
- ASX - By Stock
- RAP
- FDA Prediction
FDA Prediction, page-20
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online